Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP720723.RAkswjyZP3dxI8zcChOnm5iw96JmgtyXWBgASaAfDkVjU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP720723.RAkswjyZP3dxI8zcChOnm5iw96JmgtyXWBgASaAfDkVjU130_assertion type Assertion NP720723.RAkswjyZP3dxI8zcChOnm5iw96JmgtyXWBgASaAfDkVjU130_head.
- NP720723.RAkswjyZP3dxI8zcChOnm5iw96JmgtyXWBgASaAfDkVjU130_assertion wasGeneratedBy ECO_0000203 NP720723.RAkswjyZP3dxI8zcChOnm5iw96JmgtyXWBgASaAfDkVjU130_provenance.
- NP720723.RAkswjyZP3dxI8zcChOnm5iw96JmgtyXWBgASaAfDkVjU130_assertion wasDerivedFrom befree-20140225 NP720723.RAkswjyZP3dxI8zcChOnm5iw96JmgtyXWBgASaAfDkVjU130_provenance.
- NP720723.RAkswjyZP3dxI8zcChOnm5iw96JmgtyXWBgASaAfDkVjU130_assertion SIO_000772 20194893 NP720723.RAkswjyZP3dxI8zcChOnm5iw96JmgtyXWBgASaAfDkVjU130_provenance.
- NP720723.RAkswjyZP3dxI8zcChOnm5iw96JmgtyXWBgASaAfDkVjU130_assertion evidence source_evidence_literature NP720723.RAkswjyZP3dxI8zcChOnm5iw96JmgtyXWBgASaAfDkVjU130_provenance.
- NP720723.RAkswjyZP3dxI8zcChOnm5iw96JmgtyXWBgASaAfDkVjU130_assertion description "[Patients with refractory anemia with ring sideroblasts and thrombocytosis (RARS-T) are difficult to treat because the cytoreductive treatment might be beneficial for the thrombocytosis component but harmful for the RARS component.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP720723.RAkswjyZP3dxI8zcChOnm5iw96JmgtyXWBgASaAfDkVjU130_provenance.